Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Am J Obstet Gynecol. 2019 Jun 12;221(3):233.e1–233.e16. doi: 10.1016/j.ajog.2019.06.004

Table 3.

Activity Assessment Scale Changes from Baseline to 3 Months After Surgery Modeling Outcome as Change from Baseline1

All Surgical Treatments (N=373) ULS Surgical Treatment (N=187) SSLF Surgical Treatment (N=186) Surgical Treatment Difference
Variable Time Frame Statistic Estimate Adjusted P-value 2 Estimate Adjusted P-value 2 Estimate Adjusted P-value 2 Adjusted Mean Difference (95% CI) 3 Adjusted P-value 3
Overall AAS Score 4
Baseline Adjusted Mean (SE, N) 78.03 (1.80, 370) -- 78.10 (1.99, 185) -- 77.96 (2.00, 185) -- 0.15 (−3.26, 3.56) 0.931
Baseline Min to Max 25 to 100 25 to 100 25 to 100
2 week change Adjusted Mean (SE, N) −0.30 (1.93, 344) 0.878 2.48 (2.19, 170) 0.258 −3.07 (2.20, 174) 0.163 5.55 (1.47, 9.63) 0.008
2 week change Min to Max −77 to 73 −74 to 73 −77 to 54
4–6 week change Adjusted Mean (SE, N) 9.24 (1.92, 364) <0.001 9.73 (2.17, 182) <0.001 8.76 (2.18, 182) <0.001 0.97 (−3.06, 4.99) 0.638
4–6 week change Min to Max −53 to 73 −51 to 73 −53 to 54
3 month change Adjusted Mean (SE, N) 13.79 (1.94, 332) <0.001 14.11 (2.20, 168) <0.001 13.47 (2.22, 164) <0.001 0.64 (−3.49, 4.76) 0.762
3 month change Min to Max −42 to 63 −42 to 63 −42 to 58
Sedentary Activities Scale 5
Baseline Adjusted Mean (SE, N) 30.41 (0.64, 370) -- 30.35 (0.71, 185) -- 30.47 (0.71, 185) -- −0.12 (−1.33, 1.09) 0.845
Baseline Min to Max 9 to 36 9 to 36 9 to 36
2 week change Adjusted Mean (SE, N) −1.79 (0.70, 355) 0.012 −0.48 (0.80, 177) 0.547 −3.10 (0.80, 178) <0.001 2.62 (1.13, 4.10) 0.001
2 week change Min to Max −30 to 27 −30 to 27 −25 to 18
4–6 week change Adjusted Mean (SE, N) 2.27 (0.70, 365) 0.001 2.54 (0.80, 182) 0.002 2.00 (0.80, 183) 0.013 0.54 (−0.94, 2.02) 0.472
4–6 week change Min to Max −20 to 27 −18 to 27 −20 to 23
3 month change Adjusted Mean (SE, N) 3.68 (0.71, 336) <0.001 4.00 (0.81, 168) <0.001 3.37 (0.81, 168) <0.001 0.62 (−0.89, 2.14) 0.418
3 month change Min to Max −18 to 27 −18 to 27 −18 to 23
Ambulatory Activities Scale
Baseline Adjusted Mean (SE, N) 21.47 (0.58, 371) -- 21.58 (0.65, 185) -- 21.36 (0.65, 186) -- 0.22 (−0.89, 1.32) 0.701
Baseline Min to Max 2 to 27 2 to 27 5 to 27
2 week change Adjusted Mean (SE, N) 0.64 (0.62, 355) 0.303 1.27 (0.70, 176) 0.072 0.01 (0.71, 179) 0.986 1.26 (−0.05, 2.57) 0.059
2 week change Min to Max −20 to 25 −20 to 25 −20 to 20
4–6 week change Adjusted Mean (SE, N) 2.49 (0.62, 366) <0.001 2.63 (0.70, 182) <0.001 2.35 (0.71, 184) 0.001 0.28 (−1.02, 1.57) 0.675
4–6 week change Min to Max −20 to 25 −20 to 25 −18 to 20
3 month change Adjusted Mean (SE, N) 3.65 (0.63, 337) <0.001 3.58 (0.71, 168) <0.001 3.72 (0.71, 169) <0.001 −0.14 (−1.46, 1.19) 0.841
3 month change Min to Max −16 to 23 −16 to 18 −14 to 23
Work/Exercise Activities Scale
Baseline Adjusted Mean (SE, N) 24.76 (0.97, 369) -- 24.93 (1.08, 184) -- 24.59 (1.08, 185) -- 0.34 (−1.50, 2.18) 0.715
Baseline Min to Max 2 to 36 3 to 36 2 to 36
2 week change Adjusted Mean (SE, N) 0.42 (1.11, 310) 0.703 1.43 (1.26, 154) 0.257 −0.58 (1.27, 156) 0.645 2.01 (−0.40, 4.43) 0.102
2 week change Min to Max −36 to 32 −36 to 23 −36 to 32
4–6 week change Adjusted Mean (SE, N) 4.64 (1.09, 352) <0.001 4.48 (1.24, 177) <0.001 4.81 (1.25, 175) <0.001 −0.33 (−2.66, 1.99) 0.778
4–6 week change Min to Max −32 to 30 −27 to 27 −32 to 30
3 month change Adjusted Mean (SE, N) 7.11 (1.10, 329) <0.001 7.05 (1.25, 167) <0.001 7.17 (1.26, 162) <0.001 −0.11 (−2.49, 2.26) 0.925
3 month change Min to Max −25 to 32 −18 to 27 −25 to 32
1

The analyses for each outcome of interest were performed on the modified intent to treat population (mITT) which includes all participants that were eligible, gave consent, were randomized to both the PMT and surgical interventions, and for whom the outcome was assessed (i.e. non-missing). For analyses assessing each outcome’s change from baseline to a follow-up visit, all adjusted means, mean differences, standard errors, 95% confidence intervals, and p-values for outcomes were obtained from general linear models adjusting for randomized surgical intervention, randomized PMT intervention, visit, interaction between visit and randomized surgical intervention, interaction between visit and randomized PMT intervention, and three-way interaction between visit and randomized surgical intervention and randomized PMT intervention, concomitant hysterectomy, age at surgical randomization, race (white, black, other), ethnicity, public insurance, and private insurance while controlling for a random surgeon effect (if found statistically significant) and repeated subject visits. All tests were conducted at a significance level of 0.05.

2

This adjusted p-value corresponds to the test assessing if there was a statistically significant change from baseline.

3

This adjusted p-value corresponds to the test assessing if there was a statistically significant difference in the outcome between the two surgical treatments.

4

The effect of surgery varies across the PMT groups and across visits (p=0.042). See table 4 for the effect of randomized surgical intervention within the PMT and non-PMT groups.

5

The effect of surgery varies across the PMT groups and across visits (p=0.011). See table 4 for the effect of randomized surgical intervention within the PMT and non-PMT groups